February 12, 2020

Zomedica Announces $2.5 Million Registered Direct Offering

February 11, 2020

Zomedica Files U.S. Patent Application for Fecal Parasite Detection

January 30, 2020

Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020

January 23, 2020

Zomedica to Focus on TRUFORMA™ Commercialization

January 20, 2020

Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform

December 3, 2019

Zomedica Announces Management Changes

November 13, 2019

Zomedica Expands ZM-006 Pilot Efficacy Study

November 12, 2019

Zomedica Announces Third Quarter 2019 Financial Results

November 5, 2019

Zomedica Announces 2019 Annual Meeting Results

October 31, 2019

Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study